ACS Symposium Series
eBook - PDF

ACS Symposium Series

  1. English
  2. PDF
  3. Available on iOS & Android
eBook - PDF

ACS Symposium Series

Book details
Table of contents
Citations

Frequently asked questions

Simply head over to the account section in settings and click on “Cancel Subscription” - it’s as simple as that. After you cancel, your membership will stay active for the remainder of the time you’ve paid for. Learn more here.
At the moment all of our mobile-responsive ePub books are available to download via the app. Most of our PDFs are also available to download and we're working on making the final remaining ones downloadable now. Learn more here.
Both plans give you full access to the library and all of Perlego’s features. The only differences are the price and subscription period: With the annual plan you’ll save around 30% compared to 12 months on the monthly plan.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes, you can access ACS Symposium Series by Jaan A. Pesti, Ahmed F. Abdel-Magid, Rajappa Vaidyanathan, Matthew Maddess, John McIntosh, Wonsuk Chang, Trung Cao, Natalia Dyatkina, Sébastien Lemaire, Marija Prhavc, Simon Wagschal, Jun Liang, Jie Xu, Scott H. Watterson, Steven R. Wisniewski, Seb Caille, Brian S. Lucas, T. G. Murali Dhar, William , Jaan A. Pesti, Ahmed F. Abdel-Magid, Rajappa Vaidyanathan in PDF and/or ePUB format, as well as other popular books in Physical Sciences & Chemistry. We have over one million books available in our catalogue for you to explore.

Information

Publisher
American Chemical Society
Year
2022
ISBN
9780841297326
Topic
Physical Sciences
Subtopic
Chemistry
Index
Chemistry

Table of contents

  1. Complete Accounts of Integrated Drug Discovery and Development: Recent Examples from the Pharmaceutical Industry. Volume 4
  2. ACS Symposium Series1423
  3. Foreword
  4. Preface
  5. Discovery and Chemical Development of Uvelostinag (MK-1454): A Therapeutic Cyclic Dinucleotide Agonist of the Stimulator of Interferon Gene
  6. Discovery and Chemical Development of Adafosbuvir, a Nucleoside Phosphoramidate Prodrug for the Treatment of Hepatitis C Infection
  7. Discovery and Development of a Highly Potent, Orally Bioavailable Estrogen Receptor Full Antagonist and Degrader: Giredestrant (GDC-9545) for Estrogen Receptor-Positive Breast Cancer
  8. A Twisted Road to the Discovery and Chemical Development of BMS-986142: A Reversible Inhibitor of BTK Conformationally Constrained by Two Rotationally Stable Atropisomeric Axes
  9. Discovery of AMG 232, a Small Molecule Disrupting the p53-MDM2 Protein–Protein Interaction and Development of a Validation-Ready Process for Its Manufacture
  10. The Discovery and Chemical Development of BMS-986251: A Selective RORγt Inverse Agonist for the Potential Treatment of Autoimmune Diseases
  11. Discovery and Chemical Development of Amcenestrant: An Oral Selective Estrogen Receptor Degrader (SERD) for the Treatment of Estrogen Receptor Positive Breast Cancer
  12. Development and Optimization of the Manufacturing Process for RNA-Splicing Modifier Risdiplam RG7916
  13. Past, Present, and Future: A Changing Paradigm for Process Chemistry
  14. Editors’ Biographies
  15. Indexes
  16. Author Index
  17. Subject Index
  18. Preface
  19. Discovery and Chemical Development of Uvelostinag (MK-1454): A Therapeutic Cyclic Dinucleotide Agonist of the Stimulator of Interferon Gene
  20. Discovery and Chemical Development of Adafosbuvir, a Nucleoside Phosphoramidate Prodrug for the Treatment of Hepatitis C Infection
  21. Discovery and Development of a Highly Potent, Orally Bioavailable Estrogen Receptor Full Antagonist and Degrader: Giredestrant (GDC-9545) for Estrogen Receptor-Positive Breast Cancer
  22. A Twisted Road to the Discovery and Chemical Development of BMS-986142: A Reversible Inhibitor of BTK Conformationally Constrained by Two Rotationally Stable Atropisomeric Axes
  23. Discovery of AMG 232, a Small Molecule Disrupting the p53-MDM2 Protein–Protein Interaction and Development of a Validation-Ready Process for Its Manufacture
  24. The Discovery and Chemical Development of BMS-986251: A Selective RORγt Inverse Agonist for the Potential Treatment of Autoimmune Diseases
  25. Discovery and Chemical Development of Amcenestrant: An Oral Selective Estrogen Receptor Degrader (SERD) for the Treatment of Estrogen Receptor Positive Breast Cancer
  26. Development and Optimization of the Manufacturing Process for RNA-Splicing Modifier Risdiplam RG7916
  27. Past, Present, and Future: A Changing Paradigm for Process Chemistry
  28. Editors’ Biographies
  29. Indexes
  30. Author Index
  31. Subject Index